相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics
Nicolas Penel et al.
INVESTIGATIONAL NEW DRUGS (2010)
Multi-institutional prognostic factor analysis of patients (pts) enrolled in phase I (Ph I) oncology trials: Can pts selection be improved?
D. Olmos
JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
S. Postel-Vinay et al.
BRITISH JOURNAL OF CANCER (2009)
Survival of Patients in a Phase 1 Clinic The M. D. Anderson Cancer Center Experience
Jennifer Wheler et al.
CANCER (2009)
Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials
Hendrik-Tobias Arkenau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Participants in phase 1 oncology research trials - Are they vulnerable?
Justine Seidenfeld et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Further evidence of clinical benefit associated with participation in phase I oncology trials
M. Markman
BRITISH JOURNAL OF CANCER (2008)
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
H-T Arkenau et al.
BRITISH JOURNAL OF CANCER (2008)
Identification of factors limiting patient recruitment into phase I trials: A study from the Royal Marsden Hospital
Vasilios Karavasilis et al.
EUROPEAN JOURNAL OF CANCER (2008)
90-Days mortality rate in patients treated within the context of a phase-I trial: How should we identify patients who should not go on trial?
Hendrik-Tobias Arkenau et al.
EUROPEAN JOURNAL OF CANCER (2008)
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy
A. Italiano et al.
ANNALS OF ONCOLOGY (2008)
Prognostic factors among cancer patients with good performance status screened for phase I trials
Nicolas Penel et al.
INVESTIGATIONAL NEW DRUGS (2008)
Relaxing the rule of ten events per variable in logistic and Cox regression
Eric Vittinghoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital
Jeremy Ho et al.
BMC CANCER (2006)
Risks and benefits of phase 1 oncology trials, 1991 through 2002
E Horstmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Overall C as a measure of discrimination in survival analysis:: model specific population value and confidence interval estimation
MJ Pencina et al.
STATISTICS IN MEDICINE (2004)
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials
TG Roberts et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents
C Han et al.
BRITISH JOURNAL OF CANCER (2003)
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials
T Bachelot et al.
ANNALS OF ONCOLOGY (2000)
分享论文
